Law firm Mills & Reeve has appointed Dan Braithwaite as a principal associate in its health and social care mergers and acquisitions practice.
Anthony Collins: Laura Jordan
Law firm Anthony Collins (AC) has appointed Laura Jordan as a partner for its health and social care offering.
Jordan was previously legal director, company secretary, and data protection officer at Voyage Care and helped establish its in-house legal team during her eight-year tenure. Before that, she spent seven years as a corporate finance and private equity lawyer at Pinsent Masons.
Jordan said: “This is an exciting opportunity to grow the corporate work here at Anthony Collins, building on its already strong market position in the health and social care sector. I chose AC because of its service-first ethos and commitment to improving lives, communities and society through its work and I’m looking forward to using my experience to help clients achieve their goals.
“It was a privilege to use my legal skills in-house at Voyage Care to serve my colleagues and the people they support. Therefore, it is important for me to still be able to serve those who are committed to improving lives and to work alongside lawyers who care about their impact on society. The latter is evident from Anthony Collins achieving B Corp certification. I am eager to start my new role and meet both clients and colleagues at Anthony Collins.”
Matthew Wort, senior partner at Anthony Collins, added: “We consistently seek out individuals who share our commitment to working towards creating a positive impact in society and help improve lives with the work that we do.
“Laura is a fantastic addition to our health and social care sector team and I am confident that she will bring great insight to our clients to support them in the valuable work they do as we continue to grow the support we provide to our clients across our specialist sectors.”
Latest Executive Moves
Cancer Research Horizons has appointed Jonathan Tobin and Genghis Lloyd-Harris as advisory investors-in-residence in its ventures team.Pharma